The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Aim
To present an overview of exendin(9‐39)NH2 usage as a scientific tool in humans and provide recommendations for dosage and infusion regimes.
Methods
We systematically searched the literature on exendin(9‐39)NH2 and included for review 44 clinical studies reporting use of exendin(9‐39)NH2 in humans.
Results
Exendin(9‐39)NH2 binds to the orthosteric binding site of the glucagon‐like peptide‐1...